Oxana Schmidt
TUM Klinikum(DE)Technical University of Munich(DE)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Sarcoma Diagnosis and Treatment, CAR-T cell therapy research, Cancer-related gene regulation, Immunotherapy and Immune Responses
Most-Cited Works
- → Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma(2015)59 cited
- → Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis(2021)43 cited
- → Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity(2016)32 cited
- → Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing Sarcoma(2020)31 cited
- → The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma(2017)26 cited
- → The posteriorHOXDlocus: Its contribution to phenotype and malignancy of Ewing sarcoma(2016)25 cited
- → Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells(2017)25 cited
- → Yersinia outer protein YopE affects the actin cytoskeleton in Dictyostelium discoideumthrough targeting of multiple Rho family GTPases(2009)22 cited
- → The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma(2016)17 cited
- → Matrix mineralization controls gene expression in osteoblastic cells(2018)16 cited